Provectus Biopharmaceuticals, Inc. (PVCT)

PVCT Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-3.1	-3.55	-6.5	-8.43	-8.38
Depreciation & Amortization	0.01	0.01	0.01	0.24	0.69
Share-Based Compensation	0	0	0.02	0.13	0.02
Other Operating Activities	0.52	0.5	5.45	3.96	1.48
Operating Cash Flow	-2.57	-3.04	-1.01	-4.09	-6.19
Common Stock Issued	0	0	0.96	0.42	0.27
Other Financing Activities	2.19	1.37	3.06	3.18	6.49
Financing Cash Flow	2.19	1.37	4.02	3.6	6.75
Net Cash Flow	-0.4	-1.68	3.01	-0.49	0.54
Free Cash Flow	-2.57	-3.04	-1.01	-4.09	-6.19
Free Cash Flow Margin	-461.17%	-307.52%	-	-	-
Free Cash Flow Per Share	-0.01	-0.01	-0.00	-0.01	-0.02

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.